bet9¹ÙÍø EU divests stake in Chase Pharmaceuticals to Allergan

bet9¹ÙÍø announces Q2 FY17 results - Improved profitability in base business & Strengthened R&D pipeline

bet9¹ÙÍø Receives EIR from the US FDA for its Indore facility

bet9¹ÙÍø Receives Final Approval for Generic Enablex® Tablets

bet9¹ÙÍø Receives Final Approval for Generic Wellbutrin XL® Tablets

bet9¹ÙÍø announces Q1 FY17 results Performance reflects continued momentum in key markets and improvement in base EBITDA margins

bet9¹ÙÍø names Umang Vohra as MD & Global CEO; Samina Vaziralli is Executive Vice-Chairman

bet9¹ÙÍø joins global movement to eliminate viral hepatitis by 2030

bet9¹ÙÍø to launch South Africa’s first Biotech manufacturing facility

Nacimbio launches complex programme for antiretroviral drugs production

Subscribe to